JACOBS LEVY EQUITY MANAGEMENT, INC

Position in OGN — Organon & Co.

CIK 884414 FLORHAM PARK, NJ

Position in OGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$351,355

-$23,410,687 QoQ

Shares Held

58,657

-95.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $75,542,759 across 4 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	707,023	$40,738,665
2	LLY	ELI LILLY & Co	25,294	$30,338,384
3	MRK	Merck & Co., Inc.	32,254	$4,144,639
4	SCLX	Scilex Holding Co	41,163	$321,071

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$351,355	58,657	-95.3%	Shares	Sole	2026-05-15
2024-09-30	$23,762,042	1,242,135	+303.8%	Shares	Sole	2024-11-14
2024-06-30	$6,367,941	307,630	+0.7%	Shares	Sole	2024-08-14
2024-03-31	$5,740,542	305,348	-66.2%	Shares	Sole	2024-05-15
2023-12-31	$13,021,649	903,027	-5.4%	Shares	Sole	2024-02-14
2023-09-30	$16,571,022	954,552	-9.8%	Shares	Sole	2023-11-17
2023-06-30	$22,023,139	1,058,296	+48.0%	Shares	Sole	2023-08-14
2023-03-31	$16,816,117	714,971	+249.2%	Shares	Sole	2023-05-15
2022-12-31	$5,718,080	204,729	-45.7%	Shares	Sole	2023-02-14
2022-09-30	$8,825,590	377,162	+59.7%	Shares	Sole	2022-11-15
2022-06-30	$7,968,375	236,100	+57.2%	Shares	Sole	2022-08-15
2022-03-31	$5,244,774	150,151	+313.7%	Shares	Sole	2022-05-16
2021-09-30	$1,190,244	36,299	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.